FDA Alignment to Advance ProstACT Global Phase 3 Trial

Go back to FDA Alignment to Advance ProstACT Global Phase 3 Trial
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.84 --0 (-0%)
Previous Close $11.84    52 Week High $2.18 
Open $11.84    52 Week Low $0.30 
Day High $11.84    P/E N/A 
Day Low $11.84    EPS $-3.32 
Volume 3,292       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.84 --0 (-0%)
Previous Close $11.84    52 Week High $2.18 
Open $11.84    52 Week Low $0.30 
Day High $11.84    P/E N/A 
Day Low $11.84    EPS $-3.32 
Volume 3,292